Clinical Trial Update: Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update on defibrotide for sickle cell disease–related acute chest syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Defibrotide (defibrotide)

Snippet

Sponsor: New York Medical College | Conditions: Sickle Cell Disease, Acute Chest Syndrome | Phase 2 | Status: COMPLETED